In the current study we wish to investigate the effects on glucagon-like peptide-1 (GLP-1) of a neprilysin inhibitor
Glucagon-like peptide-1(GLP-1) is secreted during a meal and increases glucose induced insulin secretion. The enzyme dipeptidyl peptidase 4(DPP-4) cleaves intact GLP-1 within minutes and DPP-4 inhibitors are therefore used for treatment of diabetic hyperglycemia. A few animal studies have implicated the enzyme neutral endopeptidase 24.11 (24.11) in the degradation of GLP-1 but if this is the case in humans is unknown. We therefore administered a NEP inhibitor, 194mg sacubitril, a DPP-4 inhibitor (sitagliptin 100mg the night before and 100mg 2 hours before), both, or place, to nine healthy men during a standardized meal and measured plasma concentrations of GLP-1
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
19
University of Copenhagen
Copenhagen, Denmark
GLP-1
changes in plasma GLP-1 using immunological methods: intact and total GLP-1
Time frame: 3 hours after treatment ( during the subsequent standardized meal)
C-peptide
changes in C-peptide using immunological methods
Time frame: 3 hours after treatment ( during the subsequent standardized meal)
Glucagon
Changes in Plasma glucagon concentrations using different analytical methodologies
Time frame: 3 hours after treatment ( during the subsequent standardized meal)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.